Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wetzler

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Blood|September 15, 1991
Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activityZ Estrov, R Kurzrock, M Wetzler, et al.
Cancer Research|March 14, 2001
A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blastsZ Xia, R R Salzler, D P Kunz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
Calcium requirements for increased complement receptor expression during neutrophil activationM Berger, D L Birx, E M Wetzler, et al.
The New England Journal of Medicine|December 9, 1976
Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiencyS H Polmar, R C Stern, A L Schwartz, et al.
The American Journal of Medicine|November 1, 1990
A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemiaM Wetzler, M Talpaz, E S Kleinerman, et al.
Experimental Hematology|January 1, 1993
Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineageR Kurzrock, H Kantarjian, M Wetzler, et al.
Infection Control and Hospital Epidemiology|January 12, 2016
Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic MalignanciesNikolaos G Almyroudis, Ryosuke Osawa, George Samonis, et al.
Bone Marrow Transplantation|January 11, 2000
Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantationJ Schriber, B Milk, D Shaw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
Meningococcal porin PorB binds to TLR2 and requires TLR1 for signalingPaola Massari, Alberto Visintin, Jay Gunawardana, et al.
The Journal of Infectious Diseases|August 7, 1999
The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porinF G Mackinnon, Y Ho, M S Blake, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Blood|September 15, 1991
Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activityZ Estrov, R Kurzrock, M Wetzler, et al.
Cancer Research|March 14, 2001
A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blastsZ Xia, R R Salzler, D P Kunz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
Calcium requirements for increased complement receptor expression during neutrophil activationM Berger, D L Birx, E M Wetzler, et al.
The New England Journal of Medicine|December 9, 1976
Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiencyS H Polmar, R C Stern, A L Schwartz, et al.
The American Journal of Medicine|November 1, 1990
A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemiaM Wetzler, M Talpaz, E S Kleinerman, et al.
Experimental Hematology|January 1, 1993
Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineageR Kurzrock, H Kantarjian, M Wetzler, et al.
Infection Control and Hospital Epidemiology|January 12, 2016
Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic MalignanciesNikolaos G Almyroudis, Ryosuke Osawa, George Samonis, et al.
Bone Marrow Transplantation|January 11, 2000
Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantationJ Schriber, B Milk, D Shaw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
Meningococcal porin PorB binds to TLR2 and requires TLR1 for signalingPaola Massari, Alberto Visintin, Jay Gunawardana, et al.
The Journal of Infectious Diseases|August 7, 1999
The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porinF G Mackinnon, Y Ho, M S Blake, et al.
Pageof 16